This is a multicenter, prospective single-arm trial evaluating the safety and efficacy of the Axium MicroFX coil system in 100 aneurysms.
This is a multicenter, prospective single-arm trial evaluating the safety and efficacy of the Axium MicroFX coil system in 99 patients at 13 study centers. The primary endpoint of the trial was the anatomic occlusion of the aneurysm in the immediate post-procedure angiogram basedon the Raymond classification. Secondary endpoints included safety during the procedure, safety after the procedure, detachment system performance, stability of the embolization, and packing efficacy.
Study Type
OBSERVATIONAL
Enrollment
99
Axium™ MicroFX™ PGLA COILS to treat aneurysms
University of Florida
Gainesville, Florida, United States
Anatomic occlusion of the aneurysm
Occlusion of aneurysm based on the Raymond classification
Time frame: Immediately post-procedure
Safety during the procedure
Morbidity and mortality rate
Time frame: Discharge, up to two years
Safety post-procedure
Morbidity and mortality rate
Time frame: 3-6 months follow-up
Detachment system performance
Occurrence of detachment failure
Time frame: During procedure
Stability of embolization
Rate of change towards worsening Raymond grades
Time frame: 3-6 months follow-up
Packing efficacy
increase in packing density calculated as ration between volume of coils and the aneurysm volume
Time frame: 36- months follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.